drugset
drugset / Trial / NCT00808093

Repeat Dose Food Effect Study of GSK256073F in Healthy Adult Subjects

NCT00808093 ↗

Phase 1 Completed 30 enrolled GlaxoSmithKline
RandomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to compare the effects of fasting and fed conditions with repeat doses of GSK256073F in HVT subjects.

Timeline

Start
2008-05-12
Primary completion
2008-08-27
Completion
2008-08-27

Drugs

EvaluationDrugModalityDoseRoute
Subject GSK256073 Unknown 100 mg —

Indications

hyperlipidemia